Sidney Kimmel Cancer Center Executive Committee
Andrew Chapman, DO, FACP
Interim Enterprise Director, Sidney Kimmel Cancer Center and Executive Vice President of Oncology Services, Jefferson Health
Andrew Chapman, DO, is the Interim Executive Vice President of Oncology Services at Jefferson Health and Enterprise Director of the Sidney Kimmel Cancer Center, one of only 71 National Cancer Institute (NCI)-designated cancer centers nationwide. Dr. Chapman is currently overseeing cancer services and cancer research at all SKCC – Jefferson Health sites throughout the Greater Philadelphia region, reporting directly to Stephen K. Klasko, MD, MBA, President of Thomas Jefferson University and CEO of Jefferson Health. He is Chief of Cancer Services for SKCC; Co-director of the Jefferson Senior Adult Oncology Center; Professor and Vice Chair of Clinical Operations for the Department of Medical Oncology; and Clinical Professor in the Jefferson College of Nursing.
Dr. Chapman is a practicing medical oncologist with broad expertise in the evaluation and management of neoplastic diseases. His clinical and research interests center on the specialized needs of the older adult with cancer, and he helped establish the multidisciplinary Senior Adult Oncology Center at SKCC more than 10 years ago. One of the first of its kind in the U.S., the center continues to set the standard model for interprofessional care delivery for older adults with cancer.
As Chief of Cancer Services, Dr. Chapman oversees the consolidated cancer services across the enterprise health system, which includes medical oncology, radiation oncology, surgical oncology, and nursing. His research in cancer care delivery has led to the implementation of the highest quality cancer care delivery model at all Jefferson sites.
Dr. Chapman successfully enacted the Patient Centered Specialty Practice and Oncology Medical Home models with certification by the National Committee for Quality Assurance (NCQA) and extended the availability of the Senior Adult Oncology Center to patients at the 14 Jefferson Health hospitals and hospitals in the Sidney Kimmel Cancer Center Network by incorporating telehealth.
In addition to his significant leadership experience within the Jefferson enterprise, Dr. Chapman helps guide geriatric oncology and practice growth and development at the national and
international level. He is currently a member of the Association of American Cancer Institutes Physician Clinical Leadership Initiative Steering Committee and the NCQA Patient-Centered Specialty Practice Advisory Committee. He is also an active member of the American Society of Clinical Oncology (ASCO), International Society of Geriatric Oncology, American College of Physicians, American Association for Cancer Research, American Society of Hematology, and the American Osteopathic Association.
Throughout his career, Dr. Chapman has been recognized with numerous awards and honors, including the 2020 ASCO B.J. Kennedy Award for Scientific Excellence in Geriatric Oncology, Fellowship in the American College of Physicians, and the 2018 Sidney Kimmel Medical College Outstanding Clinician Award – Subspecialty Medicine. He is regularly named one of Philadelphia magazine’s Top Doctors.
Dr. Chapman received his bachelor’s degree from the University of Pennsylvania and his medical degree from the University of Health Sciences College of Osteopathic Medicine in Kansas City, Missouri. He completed his residency at Presbyterian-University of Pennsylvania Medical Center and a fellowship in medical oncology/hematology at Fox Chase Cancer Center. Prior to joining Jefferson in 1994, he was an associate instructor at the University of Pennsylvania.
NCI–designated since 1996
- Sidney Kimmel Cancer Center
Ranked among the best hospitals for cancer care by
U.S. News & World Report
- Thomas Jefferson University Hospitals
Your Philadelphia Resource for Nationally Recognized Oncology Expertise
ONE of only 71 National Cancer Institute (NCI)-designated Cancer Centers in the U.S.
Delivering comprehensive care through 4 Advanced Care Hubs across the Delaware Valley
More than 8,900 patients seen annually
About 19% of patients enrolled in clinical trials, making us one of the highest performing cancer centers nationally (top 1-2%)
Ranked "Outstanding" by National Cancer Institute (NCI)
First U.S. clinic to offer genetic testing and counseling for men with prostate cancer
Neu Center for Supportive Medicine and Survivorship - One of the first centers to offer psychosocial support to cancer patients
Routinely ranked among the top cancer centers nationally by U.S. News & World Report